Literature DB >> 2963064

Effects of posture and ageing on circulating atrial natriuretic peptide levels in man.

B G Haller1, H Züst, S Shaw, M P Gnädinger, D E Uehlinger, P Weidmann.   

Abstract

Possible influences of posture or age on plasma immunoreactive atrial natriuretic peptide (irANP) levels and potential correlates were assessed in 12 young (age +/- s.e.m. 24 +/- 1 year) and 12 elderly (63 +/- 8 year) healthy subjects on a liberal sodium intake. The groups did not differ significantly in their basal 24-h urinary sodium excretion (210 +/- 23 versus 180 +/- 15 mmol/l). However, plasma irANP was five- to ninefold higher in the elderly (P less than 0.05-0.01). Plasma irANP averaged 167 +/- 31 and 24 +/- 3 pg/ml in the elderly and young, respectively, during recumbency, fell (P less than 0.05) to 101 +/- 21 and 11 +/- 1 pg/ml, respectively, with upright posture, and rose (P less than 0.01) to 250 +/- 51 and 50 +/- 9 pg/ml, respectively, after intravenous (i.v.) loading with 0.9% saline (2.14 l in 3 h). Supine blood pressure (BP) and plasma norepinephrine tended to be higher while renin and aldosterone levels were lower (P less than 0.01) in the elderly; the three latter variables rose (P less than 0.001) with upright posture. These findings demonstrate that in normal humans, circulating irANP levels vary with posture and ageing. These changes may have potential physiological relevance and should be considered when interpreting plasma irANP levels in pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2963064     DOI: 10.1097/00004872-198710000-00007

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  13 in total

1.  The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects.

Authors:  P Cugini; P Lucia; L Di Palma; M Re; R Canova; L Gasbarrone; A Cianetti
Journal:  Clin Auton Res       Date:  1992-04       Impact factor: 4.435

Review 2.  The aging kidney: a review -- part I.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 3.  Predicting and preventing adverse drug reactions in the very old.

Authors:  Louis Merle; Marie-Laure Laroche; Thierry Dantoine; Jean-Pierre Charmes
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

4.  Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure.

Authors:  H Meyer-Lehnert; T Bayer; H G Predel; K Glänzer; H J Kramer
Journal:  Klin Wochenschr       Date:  1991-11-26

Review 5.  Clinical aspects of changes in water and sodium homeostasis in the elderly.

Authors:  Christian A Koch; Tibor Fulop
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

Review 6.  Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly.

Authors:  P A Phillips; G P Hodsman; C I Johnston
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

7.  Atrial natriuretic peptide in liver cirrhosis with mild ascites.

Authors:  S Miyase; S Fujiyama; H Chikazawa; T Sato
Journal:  Gastroenterol Jpn       Date:  1990-06

8.  Dissociation between the secretion and renal action of endogenous atrial natriuretic peptide in the syndrome of inappropriate antidiuresis.

Authors:  D W Eadington; F M Cowan
Journal:  Postgrad Med J       Date:  1990-01       Impact factor: 2.401

9.  Kinetics of atrial natriuretic peptide in young and elderly subjects.

Authors:  A C Tan; T L Jansen; E F Termond; F G Russel; T Thien; P W Kloppenborg; T J Benraad
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 10.  Changes in the renin-angiotensin-aldosterone axis in later life.

Authors:  J Belmin; B I Lévy; J B Michel
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.